中文名 | N-Acetyl lysyltyrosylcysteine amide |
英文名 | N-Acetyl lysyltyrosylcysteine amide |
别名 | 三肽抑制剂 |
英文别名 | N-Acetyl lysyltyrosylcysteine amide N-ACETYL LYSYLTYROSYLCYSTEINE AMIDE L-Cysteinamide, N2-acetyl-L-lysyl-L-tyrosyl- N-acetyl lysyltyrosylcysteine amide(Myeloperoxidase inhibitor KYC) |
CAS | 1287585-40-3 |
化学式 | C20H31N5O5S |
分子量 | 453.56 |
密度 | 1.273±0.06 g/cm3(Predicted) |
沸点 | 902.5±65.0 °C(Predicted) |
酸度系数 | 9.18±0.10(Predicted) |
存储条件 | -20°C,避光,干燥,密封 |
体内研究 | N-Acetyl lysyltyrosylcysteine amide (KYC) significantly decreases infarct size, blood-brain barrier leakage, infiltration of myeloid cells, loss of neurons, and apoptosis in the brains of middle cerebral artery occlusion (MCAO) mice. N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily for 3-7 days) significantly reduces neurological severity scores and infarct size in MCAO mice. N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily 7 days) significantly protects BBB function and decreased neutrophil infiltration. N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily 7 days) significantly reduces microglia/macrophage activation and neuron loss in MCAO mice. N-Acetyl lysyltyrosylcysteine amide (10 mg/kg; i.p.; daily for 3-7 days) decreases apoptosis and cell injury in the brains of MCAO mice. N-Acetyl lysyltyrosylcysteine amide reduced MPO in the brains of MCAO mice. N-Acetyl lysyltyrosylcysteine amide reduces NO2Tyr and 4-HNE in MCAO mice. Animal Model: 8-10 weeks old C57BL/6J mice (middle cerebral artery occlusion (MCAO) mode) Dosage: 10 mg/kg Administration: I.p.; daily for 3-7 days Result: Significantly reduced neurological deficit and brain infarct size in mice subjected to MCAO. |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!